Carlos A. Martin
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 89 publications
World TB Day 2026: Scientific innovation across the tuberculosis continuum must now translate into global impact.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: March 21, 2026
Toward tuberculosis elimination: An update on tuberculosis vaccines in clinical trials.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: January 14, 2026
Factors Involved in Tuberculosis Recurrence in a Low-incidence Setting; Reactivation Predominates Over Reinfection in a 30-year Surveillance Study.
Journal: Open forum infectious diseases
Published: December 23, 2025
Corrigendum to "Correlation between systemic allergen desensitisation and long-term asthma protection in mice following intravenous administration of the live tuberculosis vaccine MTBVAC" [EBioMedicine 107(2024)105272] DOI: https://doi.org/10.1016/j.ebiom.2024.105272.
Journal: EBioMedicine
Published: February 27, 2025
NK cells mediate preventive efficacy of intravenous BCG against lung metastasis in mice.
Journal: Cancer gene therapy
Published: November 15, 2024
Safety, reactogenicity, and immunogenicity of MTBVAC in infants: a phase 2a randomised, double-blind, dose-defining trial in a TB endemic setting.
Journal: EBioMedicine
Published: May 28, 2024
Susceptibility testing of the live attenuated tuberculosis vaccine BCG and the vaccine candidate MTBVAC to currently WHO-recommended anti-tuberculosis drugs by the European committee on antimicrobial susceptibility testing (EUCAST) method.
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Published: February 19, 2024
Low-dose M.tb infection but not BCG or MTBVAC vaccination enhances heterologous antibody titres in non-human primates.
Journal: Frontiers in immunology
Published: February 17, 2024
Correlation between systemic allergen desensitisation and long-term asthma protection in mice following intravenous administration of the live tuberculosis vaccine MTBVAC.
Journal: EBioMedicine
Published: December 12, 2023
Live-attenuated Mycobacterium tuberculosis vaccine, MTBVAC, in adults with or without M tuberculosis sensitisation: a single-centre, phase 1b-2a, double-blind, dose-escalation, randomised controlled trial.
Journal: The Lancet. Global health
Published: September 18, 2023
Last Updated: 09/26/2026